Executive Summary
Global Rank
#-
Monthly Visits
884
Avg Duration
0m 0s
Pages/Visit
1.02
Strategic Overview
Established local presence and verifiable contact details, Niche specialization in psychotherapy and related disciplines, Multi-channel contact and social footprint for the regional audience.
Very limited web traffic and brand visibility, Lack of public leadership/team transparency, No evidence of substantial market share or network effects, Potential brand confusion with similarly named entities globally.
Our Verdict
Upside & Downside Analysis
The Bull Case
3 PointsReal, Verified Presence
- Registered address and phone numbers confirmed across website and Google Maps.
- Active business hours and local directory listings found.
Low Digital Risk
- No blacklisting, scam, or malware history.
- Absence of negative legal or regulatory signals.
Localized Service Offering
- Serves a highly targeted Moscow demographic with face-to-face and telehealth options.
- Offers diversified services (psychotherapy, neuropsychology, osteopathy, consulting).
The Bear Case
3 PointsMarket/Scale Limitations
- Extremely low monthly web traffic suggests small customer base.
- No evidence of growth plans, innovation, or competitive edge.
Opaque Ownership and Leadership
- No details about company managers or founders found online.
- Limited social proof (e.g., no LinkedIn staff, no client testimonials).
Brand Overlap Risk
- Several 'HumanLab' trademarks (mostly defunct, one in entertainment, another educational) could cause confusion if expanding outside Russia.
- Unclear trademark status within the Russian jurisdiction.
Domain Integrity
Domain active since 2018, registered via a reputable Russian registrar. Standard Hurricane Electric DNS. SSL valid but not issued by a major CA (could reflect internal or local hosting norms rather than global best practice). No security warnings found.
| Registrar | REGTIME LTD. |
|---|---|
| Domain Age | Dec 11, 2018 (7 years old) |
| Security Status |
Unlocked
SSL: localhost
|
Reputation
0 Reviews
Sentiment Analysis
No scam complaints or negative press detected. Independent review sources like Trustpilot have no listing, but professional directories and Google Maps reflect a legitimate, if small, reputation footprint.
Common Themes
Traffic Distribution
| Top Countries | Traffic Share | Trend |
|---|---|---|
|
Belarus
|
100.00% |
|
Competition
| Competitor Type | Threat Analysis |
|---|---|
| Other local psychotherapy clinics | Direct competition for same-city clients; higher reputation or better marketing could absorb clientele. |
| Major national online therapy portals | Bigger platforms can outspend and outscale on marketing, digital experience, and telehealth access. |
| Global psychology/telehealth platforms operating in Russia | Could threaten if local regulations ease up or global platforms push localization in the CIS market. |
SWOT Analysis
Strengths
- Verified address and phones in Moscow, backed by real-world presence.
- No negative digital reputation, complaints, or scam reports.
- Technologically suitable for the Russian local market.
Weaknesses
- Very low traffic and engagement.
- Opaque leadership and operational details.
- Limited geographic and channel reach.
Opportunities
- Leverage social and directory presence for deeper community engagement.
- Expand telehealth or consulting services in response to local demand.
- Improve transparency and build more client social proof for competitive edge.
Threats
- Larger therapy/health platforms could outcompete via scale or marketing.
- Potential new regulations or crackdowns on health-related digital offerings in Russia.
- Confusion with other 'HumanLab' brands if international expansion attempted.
Tech Stack
CMS & Web Stack
Runs on Tilda, a Russian-oriented website builder suited for small/local businesses. Uses nginx, jQuery, and common JS libs. Mobile optimization and anti-bot measures present.
Analytics & Marketing
Yandex Metrika used for local visitor analytics, no evidence of Google Analytics.
Infrastructure & Security
Served from a Russian hosting provider (VARITI) with DNS from Hurricane Electric. SSL is present, but not issued by a major global CA.
Key Risks
| Identified Risk | Impact | Mitigation |
|---|---|---|
| Stalled growth or inability to scale beyond a small local audience. | Medium | Focus on deepening relationships with local users and exploring targeted service diversification. |
| Brand confusion or legal disputes from existing international HUMANLAB-related trademarks. | Medium | Maintain clear Russia-only branding and monitor for any regional trademark conflicts. |
| Reputational damage from poor data/communication security given use of non-premium SSL. | High | Upgrade to a mainstream CA-issued SSL certificate, educate staff on cybersecurity hygiene, and publish a data privacy FAQ. |
| Regulatory or data policy changes targeting Russian medical or counseling businesses. | High | Regular compliance checks against new federal and local health data laws; retain legal counsel. |
Contacts
Appendix & Sources
Key Citations
-
WHOIS & SSL data via ScamAI Evidence
Domain registration, nameservers, and SSL validity extracted from WHOIS and SSL scan.
-
SimilarWeb digital footprint report
Monthly unique visits, traffic sources, and engagement metrics for Dec 2025.
-
Google Places business listing: Психологический центр Humanlab
Listing confirms physical presence, phones, hours, and geolocation.
-
USPTO Trademark search - HUMANLAB/HUMANLABEL
Reviewed all listed HUMANLAB/HUMANLABEL marks; none are active or directly competitive for psychotherapy in Russia.
-
ScamAI reviews and complaints synthesis
Summary of reputational findings and external reviews: no fraud or major red flags detected.
-
BuiltWith: Technology Profile for humanlab.moscow
Detailed breakdown of hosting, tech stack, analytics, and Russian market focus.
Data Sources Used
Disclaimer
This report synthesizes public digital signals, open registries, and crowd-sourced review data. Findings represent best-effort intelligence, not legal or investment advice. All facts were current as of Jan 2026; prospective investors should revalidate core evidence and review Russian legal, political, and economic risks before taking action.